drugset / Trial / NCT00821028

Local Paclitaxel Delivery for SFA Disease

NCT00821028

Completed 27 enrolled University of Oklahoma
NaSingle-groupOpen-labelTreatment

Summary

To see if restenosis rates of superficial femoral artery atherosclerosis with percutaneous techniques can be improved using paclitaxel.

Timeline

Start
2009-01
Primary completion
2011-12
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule Other